Internal Server Error

Lifecore - About the company

Lifecore is a public company based in Chaska (United States), founded in 1965. It operates as a Sterile injectable CDMO and sodium hyaluronate producer, advancing pharmaceutical possibilities. Lifecore has raised $19.4M in funding. The company has 12 active competitors, including 3 that have exited. Its top competitors include companies like Fidia Farma, Bloomage Biotechnology and Contipro.

Company Details

Sterile injectable CDMO and sodium hyaluronate producer, advancing pharmaceutical possibilities. This organization excels in contract development and manufacturing, specializing in sterile injectables and sodium hyaluronate production. They offer expertise in specialty formulation, aseptic filling, and final packaging of complex, injectable medical devices and pharmaceutical drug products. Services include process development, clinical and commercial manufacturing, and analytical and stability services. They provide non-animal-sourced, U.S.-made sodium hyaluronate products in various molecular weights for research, clinical, and commercial applications. They are committed to quality and compliance, holding international certifications and registrations. They partner with customers to develop and manufacture life-changing pharmaceuticals, supported by strong infrastructure and a dedicated team. They also focus on environmental, social, and corporate governance, ensuring sustainability initiatives are executed with excellence.
Email ID
*****@lifecore.com
Key Metrics
Founded Year
1965
Location
Chaska, United States
Stage
Public
Total Funding
$19.4M in 4 rounds
Latest Funding Round
Ranked
Annual Revenue
$100M - $500M as on May 31, 2025
Employee Count
275 as on Jun 30, 2026
Investment & Acquisitions
Similar Companies
Exit Details
Public

Lifecore's IPO details

Lifecore got listed on Mar 25, 2021.
Click here to take a look at Lifecore's IPO in detail
Sign up to download Lifecore's company profile

Lifecore's funding and investors

Lifecore has raised a total funding of $19.4M over 4 rounds. Its first funding round was on Dec 05, 2018. Lifecore has 2 institutional investors.

Here is the list of recent funding rounds of Lifecore:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Oct 04, 2024
4295098
Post IPO
5637461
4315214
3909673
6254332
Nov 25, 2022
2371615
Post IPO
2297313
9866376
7358142
Oct 29, 2019
1760453
Conventional Debt
1486544
2590937
3531278
1033373
lockAccess funding benchmarks and valuations. Sign up today!

Lifecore's founders and board of directors

Founder? Claim Profile

Lifecore's employee count trend

Lifecore has 275 employees as of Jun 26. Here is Lifecore's employee count trend over the years:
Employee count trend for Lifecore
lockUncover Lifecore's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Lifecore's Competitors and alternates

Top competitors of Lifecore include Fidia Farma, Bloomage Biotechnology and Contipro. Here is the list of Top 10 competitors of Lifecore, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Lifecore
Lifecore
1965, Chaska (United States), Public
Sterile injectable CDMO and sodium hyaluronate producer, advancing pharmaceutical possibilities
$19.4M
55/100
2nd
Logo for Fidia Farma
Fidia Farma
1946, Abano Terme (Italy), Acquired
Company developing proprietary treatments based on hyaluronic acid (HA) and its derivatives
-
53/100
3rd
Logo for Bloomage Biotechnology
Bloomage Biotechnology
1998, Jinan (China), Public
Manufacturer of hyaluronic acid & pharmaceutical products
-
53/100
4th
Logo for Contipro
Contipro
1990, Pardubice (Czech Republic), Funding Raised
Manufacturer of hyaluronic acid-based products
-
33/100
5th
Logo for Qingdao Kangyuan Pharmaceutica
Qingdao Kangyuan Pharmaceutica
2001, Qingdao (China), Unfunded
CDMO focused on manufacturing of hyaluronidase
-
-
33/100
6th
Logo for Saintroy Lifescience
Saintroy Lifescience
2002, Surat (India), Unfunded
Manufacturer of pharmaceutical drugs
-
-
29/100
7th
Logo for Altergon Italia
Altergon Italia
2000, Avellino (Italy), Unfunded
Provider of contract based hyaluronic acid development services
-
-
23/100
8th
Logo for Minxiang Biomedical
Minxiang Biomedical
2005, Tianjin (China), Funding Raised
CDMO focused on manufacturer of API drugs
-
23/100
9th
Logo for Viablife
Viablife
2015, Hangzhou (China), Funding Raised
CDMO focused on production of APIs
-
19/100
10th
Logo for Haiyixing Biotech
Haiyixing Biotech
2018, Guangzhou Shi (China), Unfunded
CDMO focused on manufacturing of hyaluronic acid
-
-
16/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Lifecore's competitors? Click here to see the top ones

Lifecore's Investments and acquisitions

Lifecore has a total of 1 investment in Rebus Biosystems. Lifecore has not made any acquisitions as of now.

Reports related to Lifecore

Here is the latest report on Lifecore's geography:

News related to Lifecore

lockFilter this list
Media has covered Lifecore for a total of 15 events in the last 1 year, 9 of them have been about company updates and 2 about partnerships.
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Lifecore

Explore our recently published companies
  • Synscribe - Singapore based, 2025 founded, Unfunded company
  • Native Ecology - Denver based, 2000 founded, Funding Raised company
  • MackyClyde SEO - Bangsar based, 2020 founded, Unfunded company
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford